A few days ago, during a visit to the pediatrician, the doctor told us that the rotavirus vaccines, which as we know had been withdrawn from the market, were about to be put back into circulation. This has been the case, at least with one of the commercialized brands.
The Spanish Agency for Medicines and Health Products (AEMPS) has reviewed its previous recommendations and has decided to allow the release of batches of the RotaTeq vaccine again.
The decision adopted by the AEMPS is based on the report of the European Medicines Agency, issued at the end of September, confirming that the swine circovirus fragments in the RotaTeq vaccine do not pose a health risk public and that it can continue to be marketed.
The Spanish Agency also notes in an informative note that
From the next few days there will be enough vaccine in the pharmaceutical distribution channel that can be used in accordance with the terms established in its data sheet.
About the other brand marketed, Rotarix, preventive withdrawal is maintained. In reality, vaccines were never banned altogether, as there were doses available in pharmacies with which to complete vaccines already initiated. What was not recommended was to initiate new vaccinations for babies, and the entry of more vaccines was blocked until further investigations.
Recall that since March 2010, vaccination against rotavirus has been altered in Spain by the finding of porcine circovirus DNA in these vaccines, although it has always been noted that this finding did not pose health risks.
I recognize that the conversation with the pediatrician which I talked about at the beginning came to the story that we had not given my baby all the doses of the non-mandatory pneumococcal vaccine (Prevenar). We have only given her the last dose once she has exceeded 12 months and when her older sister has started going to school, although she is also vaccinated.
However, rotavirus vaccines did get them in their day, although honestly right now after seeing everything the dance had with rotavirus vaccines I do not know if they would wear them, even considering that only in Spain there was a preventive "withdrawal" (in fact, as we say there is still in the case of the other brand, Rotarix).
Even with all these doubts that I imagine that many parents will be asked, the Spanish Association of Pediatrics is glad of this decision that makes Rotateq vaccine remarketed, because it believes in its effectiveness against rotavirus and this is a first step towards the normalization of this vaccination in Spain, for which they advocate.
